Mobility Assessment Using Surrogates in Elderly Participants
NCT ID: NCT03032341
Last Updated: 2017-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
130 participants
OBSERVATIONAL
2017-01-17
2017-04-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, these assessments are not always readily available, especially in clinical situations when acute illnesses or injuries occurred without any chance to assess the baseline status, such as acute myocardial infract, rapidly progressing sepsis or catastrophic trauma. In these cases, patients are often sedated, intubated, have altered mental status, or too unstable to perform even non-invasive testing. Although some clinicians or researchers feel that surrogate can accurately assess the patients' baseline physical function and mobility status, it was never been tested.
The investigators hypothesize that mobility assessment done on surrogates, using MAT-sf will have high compatibility with the assessment done on elderly patients. Surrogates are defined as a person who spends \>2 hours a day or 8 hours a week with the patient and accompany the patient to most of their medical appointments. The investigators will test the hypothesis at the Preoperative Assessment Clinic since this clinic sees high volume of elderly patients and patients at this clinic tend to have their caregiver with them during the appointments.
Investigators will enroll 20 patients in poor mobility group (MAT-sf \< 51.38 in men and \<45.61 in women), 20 patients into the mid-mobility group (51.38\< MAT-sf≤65.5 in men and 45.61≤MAT-sf\<54.02) and 20 patients into the high mobility group (MAT-sf\>65.5 in men and MAT-sf\>54.02 in women) for a total of 60 patients and one surrogate per patient for a total of 120 unique participants.
To assess mobility, participants will be instructed on the use of the Mobility Assessment Tool-short form (MAT-sf). The MAT-sf is a 10-item computer based assessment of mobility using animated video clips. The 10 items in the MAT-sf cover a broad range of functioning. The items include walking on level ground, a slow jog, walking outdoors on uneven terrain, walking up a ramp with and without using a handrail, stepping over hurdles, ascending and descending stairs with and without the use of a handrail, and climbing stairs while carrying bags. The items were previously selected based on individual response and information curves derived from Item Response Theory. Each item is accompanied by an animated video clip together with the responses for that question (number of minutes, number of times, yes/no). The test will be performed on an I-PAD and scores will be saved to an exportable file. The time required to do the test with instructions from the examiner is expected to be no longer than 5 minutes. While the patient is completing the MAT-sf assessment, the surrogate will be directed to a separate room to complete MAT-sf for the patient ("Do you think Mr \*\* can climb up this hill?) , so there is no interaction between the patient and the surrogate during the assessment. Investigators will measure the compatibility between patients-surrogates mobility using MAT-sf and will also assess the stability of surrogate MAT-sf.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient group
20 patient in poor mobility group (MAT-sf \< 51.38 in men and \<45.61 in women), mid-mobility group (51.38\< MAT-sf≤65.5 in men and 45.61≤MAT-sf\<54.02) and high mobility group (MAT-sf\>65.5 in men and MAT-sf\>54.02 in women) for a total of 60 patients.
No interventions assigned to this group
Surrogate group
A family member/caregiver that attends visits with the patient and will be asked to answer the Mobility Assessment Test questionnaire on behalf of the patient at the initial visit and the follow up visit 1-14 days later.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have caregiver or family who meet the criteria for surrogate as above;
* Patients scheduled for elective surgical procedures.
Exclusion Criteria
* Patients who are not able to sign their own surgical consent
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sunghye Kim
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sunghye Kim, MD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00040417
Identifier Type: -
Identifier Source: org_study_id